In our study we found that treatment of MM cells with Syk inhibitors blocked the SDF-1α mediated migration of MM cells and abrogated the survival signals provided by IL-6, TLR ligands or BM stroma. The gene discussed is IL6; the disease is Miyoshi myopathy.